THE CLINICAL CHARACTERISTICS, RELATED FACTORS AND THE EFFECTIVENESS OF THE EPLEY MANEUVER IN THE TREATMENT BENIGN PAROXYSMAL POSITIONAL VERTIGO
Main Article Content
Abstract
Background: Benign paroxysmal positional vertigo is a common type of peripheral vertigo. The pathophysiological treatment of BPPV is a trend to replace treatment with slow-acting drugs with many side effects. Objectives: To describe the clinical characteristics, evaluate the treatment results after performing the Epley maneuver in patients with benign paroxysmal positional vertigo. Materials and methods: A cross-sectional descriptive study. A study was conducted on 95 patients with benign paroxysmal positional vertigo at Can Tho Central General Hospital and Can Tho University Hospital of Medicine and Pharmacy. Data collection comprise of clinical features of BPPV, evaluation of Dix-Hallpike test results, Epley maneuver effectiveness. Results: episodes of vertigo that last one minute or less (89,5%), positive rate of Dix-Hallpike test is 85 percent, torisional nystagmus 94.1%, the Epley maneuver was effective in 85% percent of patients. Conclusion: Benign paroxysmal positional vertigo was diagnosed by Dix-Hallpike test, the case has positive Dix-Hallpike was treated by Epley maneuver, effective and inexpensive.
Keywords
Benign paroxysmal positional vertigo, Dix-Hallpike test, Epley maneuver
Article Details
References
2. B. O. Cakir (2006), What is the true incidence of horizontal semicircular canal benign paroxysmal positional vertigo? Otolaryngol Head Neck Surg. 134(3), pp. 451-4.
3. C. Evren (2017), Diagnostic value of repeated Dix-Hallpike and roll maneuvers in benign paroxysmal positional vertigo, Braz J Otorhinolaryngol. 83(3), pp. 243-248.
4. E. A. Guneri, O. Kustutan (2012), The effects of betahistine in addition to epley maneuver in posterior canal benign paroxysmal positional vertigo, Otolaryngol Head Neck Surg.146(1), pp. 104-8.
5. E. Prokopakis (2013), Canalith repositioning procedures among 965 patients with benign paroxysmal positional vertigo, Audiol Neurootol.18(2), pp. 83-8.
6. M. M. Jalali (2020), The Impact of Betahistine versus Dimenhydrinate in the Resolution of Residual Dizziness in Patients with Benign Paroxysmal Positional Vertigo: A Randomized Clinical Trial, Ann Otol Rhinol Laryngol. 129(5), pp. 434-440.
7. M. von Brevern (2007), Epidemiology of benign paroxysmal positional vertigo: a population based study, J Neurol Neurosurg Psychiatry. 78(7), pp. 710-5.
8. N. Bhattacharyya (2017), Clinical Practice Guideline: Benign Paroxysmal Positional Vertigo (Update), Otolaryngol Head Neck Surg. 156(3_suppl), pp. S1-s47.
9. R. M. Hoffman, D. Einstadter, and K. Kroenke (1999), Evaluating dizzines, Am J Med. 107(5), pp. 468-78.
10. S. Y. Moon. (2006), Clinical characteristics of benign paroxysmal positional vertigo in Korea: a multicenter study, J Korean Med Sci. 21(3), pp. 539-43.